State advisory board recommends Hep-C drug for late-stage patients only
The Drug Utilization Review Board said it would recommend Medicaid coverage for a medication dubbed Harvoni only for patients who are in the later stages of hepatitis C or have other complicating issues, such as an illness like HIV or liver transplant.
Albany Times Union - Thu, 20 Nov 2014 22:45

At The Crossroads, Part 4: New Hep C Drugs Promise A Cure, For A Big Price
Rhode Island Public Radio - Thu, 20 Nov 2014 03:15

Sovaldi – 'miracle' hepatitis C oral drug gets official nod
DAWN.com - Thu, 20 Nov 2014 18:03

France pegs Gilead hepatitis C drug at "lowest price in Europe"
Reuters - Thu, 20 Nov 2014 05:18

France strikes big hep C treatment deal for Gilead's Sovaldi
FiercePharma - Thu, 20 Nov 2014 08:25

EU approval for Gilead's hep C combo Harvoni
PMLiVE - Thu, 20 Nov 2014 02:40

Hep C Drugs Cost FL Medicaid $30M So Far
Health News Florida - Tue, 18 Nov 2014 15:48



Europe gives green light to AbbVie hepatitis C drugs, others
LONDON (Reuters) - European regulators recommended approval for two drugs made by AbbVie to treat hepatitis C, both of which belong to a new generation of medicines that have proved effective in treating a condition that is the most common cause of ...
Reuters - Fri, 21 Nov 2014 04:25

AbbVie (ABBV) Hepatitis C Drugs Win The Nod Of European Regulators
Bidness ETC - Sat, 22 Nov 2014 04:56

EMA Panel Backs Exviera, Viekirax for Chronic Hepatitis C
Medscape - Fri, 21 Nov 2014 13:11

AbbVie gets an EU green light for its next-gen hep C treatment
FierceBiotech - Fri, 21 Nov 2014 05:19

The dirty motivation behind Gilead's hepatitis C agreement
Up to 150 million people worldwide suffer from chronic hepatitis C, which attacks the liver and, if left untreated, can lead to cirrhosis and cancer. Complications related to hepatitis C claim 500,000 lives annually. A major hurdle to treating the ...
Al Jazeera America - Thu, 20 Nov 2014 23:03



Costly Hep C Drugs Help Drive Spending Jump
Several factors are driving the spending spike, including the introduction of expensive new hepatitis C drugs and fewer drug patent expirations than in previous years, the report found. Such expirations typically lead to savings as cheaper generics ...
WebMD - Wed, 19 Nov 2014 22:45

Drug spending tops $1 trillion on hepatitis C, cancer therapies: study
Reuters - Wed, 19 Nov 2014 20:52

So long, patent cliff. Hello, hep C and cancer. Welcome to $1.3T in global ...
FiercePharma - Thu, 20 Nov 2014 07:14



Good Week for Gilead's Hepatitis-C Treatments, UBS Says
Scripts for Gilead's Harvoni during the week ending November 14 were released today with total scripts of 3,606, up +37% w/w. These data are strong in the context of feedback at AASLD that Harvoni Rx are being denied. This implies a total franchise new ...
Barron's (blog) - Fri, 21 Nov 2014 10:12

FBR Capital Maintains Outperform Rating On Gilead (GILD) Stock
Bidness ETC - Fri, 21 Nov 2014 09:15

Gilead Sciences (GILD) Total Sovaldi Franchise Growth Returns to High Single ...
StreetInsider.com (subscription) - Fri, 21 Nov 2014 06:37



Hepatitis C testing urged for baby boomers
Confirmed hepatitis C infections are up this year in Livingston County, and health officials believe many more people may be infected without realizing it. They say that baby boomers, those born between 1945 and 1965, may be most at risk and in need of ...
Livingston Daily - Mon, 17 Nov 2014 20:06

Costly, New Hepatitis C Treatments Help Drive 12 Percent Drug Spending Jump ...
Several factors are driving the spending spike, including the introduction of expensive new hepatitis C drugs and fewer drug patent expirations than in previous years, the report found. Such expirations typically lead to savings as cheaper generics ...
WebMD - Wed, 19 Nov 2014 21:03

At The Crossroads: How Will Medicare Grapple With Hep C?
My recent story about the high cost of new hepatitis C treatments focused on the difficulty of deciding who gets these new drugs now and who has to wait. That's because, while new drugs like Sovaldi and Harvoni (both made by Gilead) promise to cure a ...
Rhode Island Public Radio - Fri, 21 Nov 2014 08:41


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014